ProSci Tafazzin Peptide

Catalog No.	Quantity
16-826-412	0.1 mg

Catalog No. 16-826-412 Supplier ProSci Supplier No. 46466P0100

Description

Used for Blocking Activity

Tafazzin Peptide is used for blocking the activity of Tafazzin antibody (catalog number 46-466). The Tafazzin antibody ships at 0.5 mg/mL and the Tafazzin Peptide ships as a 100 ug pellet. When peptide is reconstituted in 200 uL water, the concentration will be 0.5 mg/mL, identical to that of the antibody. The best starting ratio would be 1:1 (which means molar excess of peptide relative to antibody when identical volumes are mixed). Mix equal volume of peptide and antibody at the required dilution and leave at ambient temperature for 20 minutes. Then incubate and develop in parallel two blots: one with the antibody and one with the antibody which has been pre-absorbed with the provided peptide.

Specifications

• Gene ID (Entrez): 6901
• Species: Human
• Accession Number: NP_000107.1, NP_851828.1, NP_851829.1, NP_851830.1
• Common Name: tafazzin
• Content And Storage: Store at -20°C. When reconstituted minimize freezing and thawing.
• Format: Lyophilized
• Formulation: Tafazzin peptide is supplied as 100 μg of dried peptide. When the peptide is reconstituted in 200 μL water, the concentration will be 0.5 mg/mL
• For Use With (Application): Blocking Assay
• Gene Symbol: TAZ
• Quantity: 0.1 mg
• Sequence: Tafazzin peptide corresponds to 12 amino acids of Tafazzin.
• Synonym: EFE, BTHS, EFE2, G4.5, Taz1, CMD3A, LVNCX, Tafazzin